Market Overview:
The global vaccines administered orally market is expected to grow at a CAGR of 9.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as rising demand for oral vaccines due to their ease of administration and growing awareness about the benefits of oral vaccines over traditional injectable vaccines. In addition, increasing investments by vaccine manufacturers in research and development (R&D) for new oral vaccine formulations is also contributing to the growth of this market. On the basis of type, human vaccines accounted for the majority share of the global Oral Vaccines Administered Orally Market in 2017. This segment is expected to continue its dominance during the forecast period owing to rising demand for human papillomavirus (HPV) and rotavirus vaccinations globally.
Product Definition:
A vaccine is a preparation of killed or weakened viruses, bacteria, or other microorganisms that is given to help the body build immunity to a disease. A vaccine can be administered orally.
Human:
The global human papillomavirus (HPV) vaccine market size was valued at USD 1.9 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period. The factors that are driving this market include increasing prevalence of cervical cancer, high risk of acquiring the infection due to lack of immune response, and government initiatives for mass immunization around the world.
Animal:
Animal and its usage in vaccines administered orally is a part of immunization therapy which aims at stimulating the body's immune response to protect it from diseases by using animal material. The most commonly used animal source for vaccine development includes chicken, pig, horse, rabbit and calf muscle as well as blood. Other sources include insect (insect cells or protein), yeast (yeast proteins or DNA), algae (algal proteins or DNA) and fish.
Application Insights:
Based on the application, the market is segmented into public and private. The public vaccines are those that are administered to a large number of people such as immunization against common infectious diseases. These vaccines are generally distributed through routine health services at primary level government clinics or hospitals.
The growing prevalence of chronic diseases, especially diabetes and cancer, in various regions including North America and Europe is expected to drive demand for oral vaccine products over the forecast period. Furthermore, increasing awareness about these products coupled with rising disposable income levels in developing countries including China and India will further boost industry growth over the next eight years.
The Asia Pacific region dominated global vaccine administered orally market revenue in 2017 owing to high product penetration due to increasing investment by governments for improving healthcare infrastructure along with favorable regulations supporting innovation & manufacturing activities related to biologics & recombinant proteins used in vaccines will further propel industry growth over the forecast period (8).
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of vaccine manufacturers and an increase in government initiatives are some factors contributing to the growth of this region. For instance, according to the World Health Organization (WHO), by 2020, all children will be vaccinated against whooping cough disease or bivalent vaccines will be implemented in every country around the world.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising incidences of infectious diseases coupled with increasing target population base especially for immunization programs. In addition, growing awareness about vaccination programs and improving healthcare infrastructure are also likely to drive regional market growth over next eight years.
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the major growth drivers for the global vaccines administered orally market. Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, and parasites. These infections can cause a wide range of illnesses from mild to life-threatening conditions. According to the World Health Organization (WHO), every year around 1 million people die due to vaccine-preventable infections. This number could be reduced significantly if more people were vaccinated against these infections. The increasing incidence of infectious diseases is thus expected to drive demand for oral vaccines in the coming years.
- Growing awareness about benefits of oral vaccines: There is a growing awareness among people about the benefits of oral vaccines over traditional injectable ones. Oral vaccines are easier and more convenient to administer than injectable ones and they also provide better protection against infection as they are swallowed rather than injected into the body tissues directly like traditional injectable vaccines often do . Thus, there is an increasing demand for oral vaccine products worldwide which is expected to boost growth prospects for this market in the coming years .
Scope Of The Report
Report Attributes
Report Details
Report Title
Vaccines Administered Orally Market Research Report
By Type
Human, Animal
By Application
Public, Private
By Companies
Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol, PaxVax, Vabiotech, Tiantan Biological, EuBiologics, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
200
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global Vaccines Administered Orally Market Report Segments:
The global Vaccines Administered Orally market is segmented on the basis of:
Types
Human, Animal
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Public, Private
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- GSK
- Sanofi
- Lanzhou Institute
- Serum Institute
- Valneva
- Shanghai United Cell
- Bibcol
- PaxVax
- Vabiotech
- Tiantan Biological
- EuBiologics
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
Highlights of The Vaccines Administered Orally Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Human
- Animal
- By Application:
- Public
- Private
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Vaccines Administered Orally Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Vaccines are administered orally, which means they are taken by mouth. This type of administration is preferred because it allows for a more consistent and accurate dose to be delivered to the patient.
Some of the key players operating in the vaccines administered orally market are Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol, PaxVax, Vabiotech, Tiantan Biological, EuBiologics, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals.
The vaccines administered orally market is expected to register a CAGR of 9.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Vaccines Administered Orally Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Vaccines Administered Orally Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Vaccines Administered Orally Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Vaccines Administered Orally Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Vaccines Administered Orally Market Size & Forecast, 2020-2028
4.5.1 Vaccines Administered Orally Market Size and Y-o-Y Growth
4.5.2 Vaccines Administered Orally Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Human
5.2.2 Animal
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Public
6.2.2 Private
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Vaccines Administered Orally Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Vaccines Administered Orally Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Human
9.6.2 Animal
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Public
9.10.2 Private
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Human
10.6.2 Animal
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Public
10.10.2 Private
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Human
11.6.2 Animal
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Public
11.10.2 Private
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Human
12.6.2 Animal
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Public
12.10.2 Private
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Human
13.6.2 Animal
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Public
13.10.2 Private
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Vaccines Administered Orally Market: Competitive Dashboard
14.2 Global Vaccines Administered Orally Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 GSK
14.3.3 Sanofi
14.3.4 Lanzhou Institute
14.3.5 Serum Institute
14.3.6 Valneva
14.3.7 Shanghai United Cell
14.3.8 Bibcol
14.3.9 PaxVax
14.3.10 Vabiotech
14.3.11 Tiantan Biological
14.3.12 EuBiologics
14.3.13 Panacea Biotec Ltd
14.3.14 Bio-Med
14.3.15 Halfkin Bio-Pharmaceuticals
